glutathione persister cells Drug-tolerant cancer are vulnerable to GPX4 inhibition Glutathione Peroxidases: An Emerging and
Glutathione Peroxidases: An Emerging and Promising Therapeutic Target for Pancreatic Cancer Treatment Additional data demonstrating that persister cells have a disabled Download Scientific Diagram Low GPX4 drives a sustained drug tolerant persister state in TNBC by a targetable adaptive FSP1 upregulation ScienceDirect hypothesis glutathione persister cells Drug tolerant persisters and immunotherapy exhibit cross resistance and share common survival mechanisms
Pay in 4 interest-free payments of $6.50 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13



